UB-TT170
seattle childrenâ€™s therapeutics
['sarcoma', "seattle children's therapeutics"]
high-risk #osteosarcoma patients w/ few treatment options need an innovative approach. dr. katie albert presents enlighten-01 #cartcell trial for teens/young adults w/ relapsed/refractory osteosarcoma using s ub-tt170 (fitc-folate). #aacr23
A nonprofit therapeutics development enterprise devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases. #CARTcells